2021
DOI: 10.1186/s13256-021-02707-7
|View full text |Cite
|
Sign up to set email alerts
|

Coronavirus disease 2019 and dengue: two case reports

Abstract: Background The pandemic of this century has overwhelmed the healthcare systems of affected countries, and all resources have been diverted to coronavirus disease 2019. At the onset, coronavirus disease 2019 can present as any other acute febrile undifferentiated illness. In tropical regions, clinicians are increasingly challenged to differentiate these febrile illnesses without the use of diagnostics. With this pandemic, many of these tropical diseases are neglected and go underreported. Dengue… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(35 citation statements)
references
References 43 publications
0
32
0
1
Order By: Relevance
“…Several tropical diseases are endemic to the Maldives, and clinicians use point-of-care test kits since many tropical diseases are indistinguishable upon presentation and can overlap with symptoms of MIS-A [ 36 , 37 , 38 ]. In the present case, the patient had a positive diagnosis of dengue IgM from ELISA, but this finding had to be carefully interpreted as false-positive dengue serology had been described in COVID-19 patients [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several tropical diseases are endemic to the Maldives, and clinicians use point-of-care test kits since many tropical diseases are indistinguishable upon presentation and can overlap with symptoms of MIS-A [ 36 , 37 , 38 ]. In the present case, the patient had a positive diagnosis of dengue IgM from ELISA, but this finding had to be carefully interpreted as false-positive dengue serology had been described in COVID-19 patients [ 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…The emergence of both dengue and COVID-19 infections have given rise to various cases of other co-infections. Several case reports from Indonesia and Thailand have shown misdiagnosis or delayed diagnosis, not only due to false-positive or false-negative interpretation, but also due to the "stigma" of COVID-19 diagnosis by the physicians themselves [13][14][15][16]. Misdiagnosis of COVID-19 as dengue also hinders isolation of patients leading to risk of airborne transmission to other patients.…”
Section: Challenges and Implicationsmentioning
confidence: 99%
“…The emergence of pathogenic coronaviruses in flavivirus endemic populations has created an urgent need for SARS-CoV-2 serological tests, which discriminate between the anti-virus antibodies and accurately assess the seroprevalence of dengue fever and COVID-19 [ 16 , 17 ]. Cross-reactivity between SARS-CoV-2 spike (S) protein and dengue envelope protein is indicated in pre-COVID-19 pandemic serum from flavivirus infection; 20% of 19 confirmed Brazilian Zika infection [ 18 ] and 22% of 70 dengue IgG positive travelers from Israel and Italy [ 19 ] show positive IgM and/or IgG reactivity in SARS-CoV-2 S RBD rapid tests and/or semi-quantitative ELISA.…”
Section: Introductionmentioning
confidence: 99%